Statement by Indian Civil Society: Need for open innovation and knowledge sharing for COVID-19 healthcare through Indian IP lawsThe Leaflet·June 24, 2020
Bombay HC directs Centre to decide representation seeking ‘compulsory licenses’ to two patented anti-TB drugsThe Leaflet·March 10, 2021
Is India’s legal framework ready to deal with sexual violence in virtual reality?Gursimran Kaur Bakshi·January 5, 2024
Policing the internet: Kerala’s increasing crackdown on free speech onlineMuhammed M.P.·December 1, 2023
Explainer Part I | Statutes that govern the election processNabeeha Naqvi and Yamina Rizvi·March 30, 2019
World TB Day coincides with the Indian Patent Office rejecting J&J’s application to extend its patent on anti-tuberculosis drug BedaquilineSarah Thanawala·March 24, 2023
Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question?Justice Prabha Sridevan·October 8, 2020
Panel discussion on Intellectual Property and the Constitution: accessibility, vaccine waivers and content creationTaera Singh·April 16, 2022
Covid19: Why aren’t you buying all doses; when will you disburse 50% of doses to states; what is the rationale for differential pricing: SC to CentreThe Leaflet·April 30, 2021